PORTLAND, Oregon, March 15, 2023 — Health Technology Innovations, Inc. (HTI) is excited to announce that Dr. Gabriella Kiss is joining HTI as a Senior Advisor. Dr. Kiss brings extensive experience in life science and Business Development to HTI. She is currently the Director of Global Strategic Account at Refeyn, Inc., where she is overseeing business with large pharma and biotech companies globally as well as driving regulatory activities. Previously, she was responsible for strategic planning and setting up all aspects of pre- and post-sale activities in North America (US and Canada) for Refeyn. Prior to Refeyn, Dr. Kiss was the Product Marketing Manager at Thermo Fisher Scientific where she developed global go-to-market strategy for products in the Single Particle Analysis. She was also the Technical Consultant and Business Development for Life Sciences for the Americas. Dr. Kiss received a BSc and MSc Biotechnology, Molecular biology, and Microbiology from University of Szeged (Szeged, Hungary). Dr. Kiss was a Postdoctoral fellow in Structural Virology at Emory University in Atlanta using cryo-electron microscopy (cryo-EM) and cryo-electron tomography (cryo-ET). She was involved in technology development with electron microscopy companies testing cutting edge technologies like Phase Plate and cryo-tomography. Dr. Kiss received a PhD in Molecular Virology from University of Reading (Reading, UK). Dr. Kiss has multiple Peer Reviewed Publications from her academic work.
